You are viewing: US Empty Capsules Market analysis
Part of: Empty Capsules Market (Global)

The US Empty Capsules Market was valued at $643.7 Million in 2025 and projected to reach to $822.1 Million by 2030, representing a compound annual growth rate of 5.0%. The US empty capsules market is poised for sustained growth through 2030, supported by the country's dominant pharmaceutical manufacturing sector and expanding nutraceutical industry.

US Empty Capsules Market (2025-2030) : Size and Share
logo-mobile
CAGR of
cagr-Chart
USD Million
MARKET SNAPSHOT
Market Size in USD 26.32 MN
Market Forecast in
CAGR
Forecast Period
Units Considered Value (USD MN)

US Empty Capsules Market Trends and Insights

  • The US market benefits from robust pharmaceutical manufacturing infrastructure, increasing demand for nutraceutical supplements, and growing preference for capsule-based drug delivery systems.
  • The US pharmaceutical and dietary supplement industries continue to drive consumption of empty capsules across gelatin and plant-based variants. In the US, empty capsules serve critical applications in pharmaceutical formulations, over-the-counter medications, and nutritional supplements.
  • The US market is characterized by stringent regulatory standards from the FDA, which ensures product quality and safety.
  • Between 2025 and 2030, the US empty capsules market will be shaped by innovations in capsule technology, rising consumer health consciousness, and expansion of contract manufacturing operations throughout the country. The US remains a dominant market for empty capsules due to its advanced healthcare ecosystem and substantial investment in pharmaceutical R&D.
  • Market participants in the US are increasingly focusing on sustainable and plant-based capsule alternatives to meet evolving consumer preferences and regulatory requirements..

Key Market Statistics

  • CAGR (2025-2030) 5.0% CAGR
  • Market Size, 2025 ~USD 643.7 Million
  • Forecast, 2030 ~USD 822.1 Million
  • Country US

US Empty Capsules Market Overview

Market Valuation :

The US empty capsules market is valued at $643.7 million in 2025 and is projected to reach $822.1 million by 2030, representing steady growth in the pharmaceutical and nutraceutical sectors.

Consistent Growth Trajectory :

The US market is expanding at a CAGR of 5.0% through 2030, driven by increasing pharmaceutical manufacturing demand and the rising popularity of capsule-based formulations among US consumers.

Strong Manufacturing Infrastructure :

The US benefits from a robust pharmaceutical manufacturing ecosystem with advanced production capabilities, stringent quality standards, and established supply chains supporting capsule production.

Dual Market Drivers :

Growth is fueled by both prescription pharmaceutical demand and the booming US dietary supplement industry, with consumers increasingly preferring capsule delivery systems for convenience and efficacy.

US Empty Capsules Market Dynamics

  • Increasing consumer preference for capsule-based supplements, coupled with ongoing pharmaceutical innovation, will drive consistent demand.
  • The market's 5.0% CAGR reflects stable expansion as manufacturers invest in advanced capsule technologies and production capacity to meet both domestic and export requirements. Regulatory compliance and quality standards in the US continue to elevate market standards, benefiting established capsule manufacturers.
  • The growing wellness trend and aging population further support demand for dietary supplements in capsule form.
  • Strategic investments in manufacturing facilities and R&D initiatives will position the US market as a key hub for empty capsule production and innovation through the forecast period..

Related Ecosystem

Pharmaceuticals

Top Technologies
  • Bioreactors
  • Analytical Testing
  • Bioanalytical Testing Services
  • Cell Counters
  • Data Management Services
Top Companies
  • Thermo Fisher Scientific Inc.
  • Merck KGaA
  • SANOFI
  • Pfizer Inc.
  • NOVARTIS

    Key Takeaways

    • The US empty capsules market is valued at $643.7 million in 2025 and will reach $822.1 million by 2030 at a 5.0% CAGR.
    • The US market is driven by strong pharmaceutical manufacturing, dietary supplement demand, and FDA regulatory compliance requirements.
    • Plant-based and vegetarian capsule alternatives are gaining traction in the US market as consumers seek sustainable options.
    • The US pharmaceutical and nutraceutical sectors will continue to be the primary growth engines for empty capsule consumption through 2030.

    Empty Capsules Market Report Scope

    Report Metric Details
    Base Year 2025
    Fastest Growing Segment SUSTAINED-RELEASE CAPSULES (Functionality)
    Forecast Period 2025–2030
    Growth Rate CAGR of 5.6% from 2025 to 2030
    Largest Segment IMMEDIATE-RELEASE CAPSULES (Functionality)
    Market Size Base Year (Billions) ~USD 3.19 (2025)
    Revenue Forecast (Billions) ~USD 4.19 (2030)
    Segments Covered Type, Raw Material, Functionality, Size, Therapeutic Application, End User

    US Empty Capsules Market Report Segmentation

    6 segment dimensions are covered across the global market.

    By Type

    • Gelatin Capsules
    • Non-Gelatin Capsules

    By Raw Material

    • Bonemeal Gelatin
    • Bovine-Derived Gelatin
    • Hydroxypropyl Methylcellulose (Hpmc)
    • Other Gelatin Sources
    • Porcine Gelatin
    • Pullulan & Starch

    By Functionality

    • Delayed-Release Capsules
    • Immediate-Release Capsules
    • Sustained-Release Capsules

    By Size

    • Size 0
    • Size 00
    • Size 000
    • Size 1
    • Size 2
    • Size 3
    • Size 4
    • Size 5

    By Therapeutic Application

    • Antacid & Antiflatulent Preparations
    • Anti-Inflammatory Drugs
    • Antianemic Preparations
    • Antibiotic & Antibacterial Drugs
    • Cardiovascular Therapy Drugs
    • Cough & Cold Drugs
    • Dietary Supplements
    • Other Therapeutic Applications

    By End User

    • Cosmetic Industry
    • Nutraceutical Industry
    • Pharmaceutical Industry
    • Research Laboratories

    US: EMPTY CAPSULES MARKET, BY END USER, 2023–2030

    Segment20232024202520262027202820292030CAGR (%)
    COSMETIC INDUSTRY90.992.196.1100.8106.2112118.4125.55.5
    NUTRACEUTICAL INDUSTRY373.3378.9396.9418.3442.4468.84985306
    PHARMACEUTICAL INDUSTRY483.8487.3509.8536.7566.9600636.6676.75.8
    RESEARCH LABORATORIES33.636.738.239.941.843.946.348.85.1
    TOTAL981.5995.11040.81095.81157.41224.81299.213815.8

    Target Audience

    • Pharmaceutical Manufacturers : US-based and international pharma companies need precise market data to optimize capsule sourcing, plan production capacity, and identify supply chain opportunities in the American market.
    • Nutraceutical & Supplement Companies : Dietary supplement manufacturers require US-specific market insights to understand demand trends, competitive positioning, and growth opportunities in the rapidly expanding wellness sector.
    • Capsule Producers & Suppliers : Empty capsule manufacturers need detailed US market analysis to assess demand forecasts, identify customer segments, and plan production investments aligned with market growth projections.
    • Investment & Private Equity Firms : Investors evaluating opportunities in the US pharmaceutical and supplement sectors require validated market data to assess growth potential, valuations, and investment returns through 2030.
    • Contract Manufacturers & CDMOs : Contract development and manufacturing organizations need US market intelligence to understand client demand, capacity planning requirements, and service expansion opportunities in capsule-based formulations.

    Key Companies in the US Empty Capsules Market

    CompanyHQOwnershipStrongest segments
    PATHEON INCNetherlandsPrivate CompanyDrug product services (finished dosage manufacturing, packaging, lifecycle management),Pharmaceutical development services (formulation, clinical trial supply),Drug substance services (API and biologics substance),
    ALLERGAN PLCIrelandPrivate CompanyMedical aesthetics and dermatology,Eye care,Neuroscience and CNS,
    HELM AGGermanyPrivate CompanyBasic Chemicals, Acids and Lyes,Plastics and Polyurethanes,Crop Protection and Fertilizers,
    SUNIL HEALTHCARE LIMITEDIndiaPublic CompanyStandard empty hard gelatin capsules (incl. BSE/TSE free, pearl, natural color),Functional and specialty capsules (liquid-fill, preservative-free, stick-free, flavored, SLS-free, non-AZO),HPMC/vegetable capsules,
    NATURAL CAPSULES LIMITEDIndiaPublic CompanyStandard hard gelatin capsule shells,Vegetarian and cellulose-based capsule shells,Enteric, fast-release, and functional capsules,
    ANHUI HUANGSHAN CAPSULE CO., LTD.ChinaPublic CompanyVacant gelatin capsules (standard),Enteric-coated / entersoluble gelatin capsules,Vegetable capsules (HPMC, pullulan, vegetable entersoluble),

    PATHEON INC

    Patheon Inc. is a Netherlands-based private company with 9,100 employees operating in the pharmaceutical and contract manufacturing sector.

    ALLERGAN PLC

    Allergan PLC is an Ireland-incorporated private company founded in 1983 with 17,400 employees, operating in the pharmaceutical and specialty healthcare industry.

    HELM AG

    Helm AG is a Germany-based private company founded in 1900 with 1,430 employees, operating in the pharmaceutical and chemical distribution industry.

    SUNIL HEALTHCARE LIMITED

    Sunil Healthcare Limited is an India-based public company founded in 1973 with 161 employees operating in the pharmaceutical sector.

    NATURAL CAPSULES LIMITED

    Natural Capsules Limited is an India-based public company founded in 1993 with 615 employees operating in the pharmaceutical capsule manufacturing industry.

    ANHUI HUANGSHAN CAPSULE CO., LTD.

    Anhui Huangshan Capsule Co., Ltd. is a China-based public company founded in 1989 with 639 employees operating in the pharmaceutical capsule manufacturing industry.

    Reasons to Buy this Report

    • Precise US Market Sizing : Access validated market data specific to the United States, with exact valuations for 2025 ($643.7M) and 2030 ($822.1M) forecasts, enabling accurate business planning and investment decisions.
    • Competitive Intelligence : Understand the US competitive landscape, manufacturing capabilities, and market dynamics unique to American pharmaceutical and supplement industries to identify growth opportunities and competitive advantages.
    • Regulatory & Compliance Insights : Gain clarity on US-specific regulatory requirements, quality standards, and compliance frameworks that impact capsule manufacturing, sourcing, and market entry strategies.
    • Segment-Specific Analysis : Identify growth drivers across US pharmaceutical and dietary supplement segments, enabling targeted marketing strategies and product development aligned with American consumer preferences.
    • Strategic Expansion Planning : Leverage US market projections and growth trends to develop informed expansion strategies, capacity planning, and investment decisions for manufacturers and suppliers entering or scaling in America.

    Frequently asked questions

    What is the current size of the US empty capsules market?

    The US empty capsules market is valued at $643.7 million in 2025 and is expected to grow to $822.1 million by 2030.

    What is the growth rate of the US empty capsules market?

    The US empty capsules market is projected to grow at a compound annual growth rate (CAGR) of 5.0% from 2025 to 2030.

    What are the main applications of empty capsules in the US?

    In the US, empty capsules are primarily used in pharmaceutical formulations, over-the-counter medications, dietary supplements, and nutraceutical products.

    What types of capsules are most popular in the US market?

    The US market includes both gelatin-based capsules and plant-based alternatives, with increasing demand for vegetarian and sustainable capsule options.

    What regulatory standards govern the US empty capsules market?

    The US empty capsules market is regulated by the FDA, which enforces strict quality, safety, and manufacturing standards for all capsule products.

    RESEARCH METHODOLOGY

    This research extensively utilized secondary sources, directories, and databases to gather valuable information for analyzing the global empty capsules market. In-depth interviews were conducted with various primary respondents, including key industry players, subject-matter experts (SMEs), C-level executives, and industry consultants, to obtain and verify important qualitative and quantitative data and assess the market's growth prospects. The global market size estimated through secondary research was then triangulated with inputs from primary research to determine the final market size.

    Secondary Research

    Secondary research was used mainly to identify and collect information for the extensive, technical, market-oriented, and commercial study of the Empty capsules market. The secondary sources used for this study includes European Federation of Pharmaceutical Industries and Associations (EFPIA), United States Food and Drug Administration (US FDA), Central Drugs Standard Control Organisation (CDSCO), Drugs Technical Advisory Board (DTAB), Pharmaceutical Research and Manufacturers of America (PhRMA), Indian Pharmaceutical Association (IPA), National Institutes of Health (NIH), World Health Organization (WHO), among others. Secondary sources also include corporate and regulatory filings, such as annual reports, SEC filings, investor presentations, and financial statements; business magazines & research journals; press releases; trade, business, and professional associations; and MarketsandMarkets Analysis. These sources were also used to obtain key information about major players, market classification, and segmentation according to industry trends, regional/country-level markets, market developments, and technology perspectives.

    Primary Research

    After an initial assessment of the global empty capsules market landscape through secondary research, comprehensive primary research was conducted. This involved conducting in-depth interviews with market experts from the demand side, including stakeholders from the pharmaceutical, nutraceutical, and cosmetic industries, as well as research laboratories. Additionally, interviews were held with key supply-side participants, such as C-suite and senior executives, product managers, and marketing and sales leaders from leading empty capsules manufacturers, distributors, and channel partners. The research covered six major regions: North America, Europe, the Asia Pacific, Latin America, the Middle East, and Africa. About 70% of the primary interviews were with supply-side participants, while 30% involved demand-side experts. Data collection methods included structured questionnaires, email correspondence, online surveys, personal interviews, and phone discussions to thoroughly understand market dynamics.

    The following is a breakdown of the primary respondents:

    Empty Capsules Market

    To know about the assumptions considered for the study, download the pdf brochure

    Market Size Estimation

    Both bottom-up and top-down approaches were used to estimate and validate the total size of the empty capsules market. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:

    A list of the major global players operating in the empty capsules market was generated.

    The revenues generated from their empty capsules product have been determined through annual reports and secondary sources (including paid databases)

    The products were mapped according to the segments of the market. Percentage shares and splits were determined based on the revenue contributed to each segment. This was verified using secondary sources and by industry experts.

    The combined revenue share of the players was estimated and then added up to 100% to derive the global empty capsules market.

    All assumptions, approaches, and individual shares/revenue estimates were validated through expert interviews.

    Global Empty Capsules Market Size: Bottom-up and Top-down Approach

    Empty Capsules Market

    Data Triangulation

    After determining the market size through the estimation process described above, the total market was divided into several segments and subsegments. To complete the overall market engineering process and obtain precise statistics for all segments and subsegments, data triangulation and market breakdown methods were used whenever applicable. The data was triangulated by analyzing various factors and trends from both the demand and supply sides.

    Market Definition

    A capsule is a form of solid oral dosage that consists of a container, usually made of gelatin or HPMC material, filled with a medicinal substance. Empty capsules are hard shells of various shapes, typically designed to hold a single dose of active ingredients. At the time of sale, these capsules are not filled with any pharmaceutical or nutraceutical ingredients. They are made in two halves: a smaller-diameter “body” that is filled and sealed with a larger-diameter “cap”.

    Stakeholders

    • Empty Capsules Manufacturing Companies
    • Pharmaceutical Companies
    • Nutraceutical Companies
    • Contract Research Organizations (CROs)
    • Contract Manufacturing Organizations (CMOs)
    • Research Laboratories & Academic Institutes.
    • Market Research & Consulting Firms
    • Regulatory Bodies

    Report Objectives

    • To define, describe, and forecast the empty capsules market based on type, raw material, functionality, size, therapeutic application, end user, and region
    • To provide detailed information regarding the major factors influencing market growth (such as drivers, restraints, opportunities, and challenges)
    • To strategically analyze micromarkets concerning individual growth trends, prospects, and contributions to the empty capsules market
    • To analyze the opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
    • To forecast the size of the market segments concerning six main regions—North America, Europe, the Asia Pacific, Latin America, the Middle East, and Africa
    • To profile the key players in the global Empty capsules market and comprehensively analyze their product portfolios, market positions, and core competencies
    • To track and analyze competitive developments such as product approvals and launches, expansions, agreements, and collaborations in the empty capsules market
    • To benchmark players within the empty capsules market using the company evaluation matrix framework, which analyzes market players based on various parameters within the broad categories of business strategies and product footprints.

    Get the Full Empty Capsules Market Report

    Full forecast, segment splits, and company analysis for all Empty Capsules Market.

    Need a Tailored Report?

    Customize this report to your needs

    Get 10% FREE Customization

    Customize This Report
    Fact checked
    DMCA.com Protection Status